Wakayama, Japan

Takahiro Ichihara



Average Co-Inventor Count = 4.0

ph-index = 1


Company Filing History:


Years Active: 2019-2020

Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: Takahiro Ichihara: Innovator in Sophorolipid Production

Introduction

Takahiro Ichihara is a notable inventor based in Wakayama, Japan. He has made significant contributions to the field of biotechnology, particularly in the production of sophorolipids. With a total of 2 patents to his name, Ichihara's work focuses on enhancing the efficiency of sophorolipid production through innovative microbial strains.

Latest Patents

Ichihara's latest patents include a sophorolipid highly-productive mutant strain. This invention provides a microorganism with a high capability for sophorolipid production. The disclosed yeast mutant strain features a polypeptide that has been deleted or deactivated, which consists of the amino acid sequence set forth in SEQ ID NO:2 or an amino acid sequence with at least 90% identity. Another significant patent is also related to a sophorolipid highly-productive mutant strain, which showcases a yeast mutant strain that has been engineered to exhibit high sophorolipid productivity. In this case, a transporter responsible for transporting Acyl-CoA to a peroxisome has been deleted or deactivated.

Career Highlights

Takahiro Ichihara is currently employed at Kao Corporation, where he continues to advance his research in microbial biotechnology. His work at Kao Corporation has positioned him as a key player in the development of sustainable and efficient production methods for valuable bioproducts.

Collaborations

Ichihara collaborates with esteemed colleagues such as Masatoshi Tohata and Fumikazu Takahashi. Their combined expertise fosters an environment of innovation and progress in their research endeavors.

Conclusion

Takahiro Ichihara's contributions to the field of sophorolipid production exemplify the impact of innovative thinking in biotechnology. His patents reflect a commitment to enhancing production capabilities through advanced microbial strains.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…